Singapore’s SwipeRx secures $27M Series B funding to accelerate growth across Southeast Asia
SwipeRx (formerly mClinica Pharmacy Solutions), a Singapore-based platform for pharmacies, announced Monday it has secured a Series B round of $27 million in equity and debt to accelerate growth across southeast asia (SEA). The round was led by Indonesia’s MDI Ventures, with participation from global investors, Bill & Melinda Gates Foundation, Johnson & Johnson Impact Ventures, SIG and existing investors.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed